|
|
Volumn 326, Issue 7395, 2003, Pages 900-
|
|
Drug companies pay out millions after overcharging Medicaid.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
DRUG COST;
DRUG INDUSTRY;
ECONOMICS;
GERMANY;
LEGAL ASPECT;
MEDICAID;
UNITED STATES;
ADOLESCENT;
ADOLESCENT PREGNANCY;
FEMALE;
GOVERNMENT;
HEALTH CARE POLICY;
HEALTH PROMOTION;
HUMAN;
PREGNANCY;
SEXUALLY TRANSMITTED DISEASE;
STATISTICS;
UNITED KINGDOM;
DRUG COSTS;
DRUG INDUSTRY;
GERMANY;
MEDICAID;
UNITED STATES;
ADOLESCENT;
FEMALE;
GOVERNMENT;
GREAT BRITAIN;
HEALTH POLICY;
HEALTH PROMOTION;
HUMANS;
PREGNANCY;
PREGNANCY IN ADOLESCENCE;
SEXUALLY TRANSMITTED DISEASES;
MLCS;
MLOWN;
|
|
EID: 0038526315
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.326.7395.900/e Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
